Latest News for: flt3

Edit

Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, ...

Nasdaq Globe Newswire 03 Nov 2025
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq ... .
Edit

CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status (Form 8-K) (Cullinan Therapeutics Inc)

Public Technologies 03 Nov 2025
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ... Menin Inhibitors and FLT3 Inhibitors in AML.
Edit

Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 ...

Nasdaq Globe Newswire 01 Oct 2025
– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML – ... .
  • 1

Article Search

tools
×
×
×
×